IBC Homepage

Meeting Agenda for 5/21/08

News from NIH

What's New?

FAQs

Forms

IBC Authority and Oversight

Recombinant DNA Categories

Registration

Extended Help for Registration

Biosafety Requirements & Resources

IBC Review/Approval & Meetings

Containment categories for commonly used agents

Human Subject Studies that Require IBC Approval

Human Subject Studies that Require IBC Approval

Printer friendly version of page

Please click on the link best describing your study and follow the corresponding instructions.

If none of the choices seem applicable to your study, please contact Janet Ives, Biosafety Officer, at X53014 or jives@safety.rochester.edu.

Introduction of Recombinant DNA (plasmids) or gene transfer vectors (including viral vectors) into human subjects.

Introduction of genetically engineered micro-organisms or infectious agents into human subjects (including live vaccines if they are experimental in nature and/or not FDA-approved for use in the specific study population).

The analysis of, or experimentation, with sera, blood products, or other specimens derived from humans in UR research laboratories or those UR labs that are NOT accredited within the College of American Pathologists (CAP) or the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).

This page last updated 5/08/08. Disclaimer